Researchers evaluated a case study and treatment of a patient who was diagnosed with schizophreniform disorder who presented at an emergency department testing positive for COVID-19.
This study identifies the correlation between racial parameters and risk of suicidal behavior in childhood-onset schizophrenia.
A systematic review examined the metabolic and cardiovascular adverse effects in commonly prescribed second-generation antipsychotics.
Significantly greater global cognitive deficits seen in those with schizophrenia who had metabolic syndrome, diabetes, hypertension
Delivery of antipsychotic drugs via the nasal cavity circumvents multiple barriers for reaching the brain but requires a vehicle with specific properties to be effective.
The researchers used various questionnaires to assess quality of life, psychiatric symptoms, sleepiness, and fatigue in those with psychosis.
While racial and ethnic disparities in health care, including in behavioral health disorders, are known, disparities during first-episode psychosis have not been fully explored.
The study authors evaluated whether psychosis transition can be predicted in patients with clinical high-risk or recent-onset depression using multimodal machine learning that integrates clinical and neurocognitive data, structural magnetic resonance imaging, and polygenic risk scores for schizophrenia.
Physical activity might not protect against schizophrenia risk.
The researchers of this study sought to quantify the difference in antipsychotic and antidepressant exposure among patients with genetically associated CYP2C19 and CYP2D6 poor (PM), intermediate (IM), and normal (NM) metabolizers.
